OPT opthea limited
Add to My Watchlist 0.00% ! 60.0¢

Ann: Becoming a substantial holder, page-16

  1. Tekvest
    14,900 Posts.
    lightbulb Created with Sketch. 1669
    clock Created with Sketch.
    15/03/25
    11:00
    Post #: 78277862
    'All the analyses on the likelihood of a successful P3 trial is around 70% with potential winnings from that many, many times over your initial stake'

    Post the analysis. It is opinion only. Historically the success rate in Phase 3 trials for Biomed research is between 50% and 60%
    Last edited by Tekvest: 15/03/25
    OPT Price at posting: 60.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
NEWS INOVIQ Kills 88% of Lung and Breast Cancer Cells with New Lab Treatment
right-arrow Created with Sketch.
STN Excellent Gold Intercepts Demonstrate Robust Apollo Hill Resource
right-arrow Created with Sketch.
NEWS Trident Infill Drilling Results Confirm Resource as Development Gets Underway
right-arrow Created with Sketch.
NEWS High-grade monazite-rich mineral sands discovery confirmed at Minta Est
right-arrow Created with Sketch.
NEWS Pilbara Exploration Identifies High-Grade Gold and Antimony Targets
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $738.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.